ELEVATE CAR T-Cell Therapy
January 2026
CAR T-cell therapy is a promising treatment option for people with myeloma. ELEVATE is a foundational toolkit focused on living well before, during and after a patient undergoes CAR T-Cell therapy. This series provides important information about the CAR T-cell therapy process, emphasizing the important role of the care partner, and outlines key advice for communicating with your healthcare team. ELEVATE includes:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
What You Should Know Before the CAR T-Cell Therapy Process
Preparing for Myeloma CAR-T Cell Therapy | What to Expect
February 13, 2026
How Has Myeloma CAR T-Cell Therapy Changed in Recent Years?
February 13, 2026
What Are Myeloma Treatment Options After CAR T-Cell Therapy?
December 18, 2025
Current and Emerging CAR T-Cell Therapy Treatment Options
December 18, 2025
Understanding the Basics | The Goals of Myeloma CAR T-Cell Therapy
December 18, 2025
What You Should Know During and After the CAR T-Cell Therapy Process
Myeloma CAR T-Cell Therapy | Long-Term Recovery
February 13, 2026
After CAR T-Cell Therapy | Essential Follow-Up & Testing
February 13, 2026
During and After Myeloma CAR T-Cell Therapy | What to Expect
February 13, 2026
Understanding Symptoms and Side Effects
CAR T-Cell Therapy Research and Clinical Trials
Research Updates From ASH | Myeloma CAR T-Cell Therapy
February 13, 2026
ELEVATE CAR T-Cell Therapy Resources
ELEVATE CAR T-Cell Therapy is brought to you by the Patient Empowerment Network. It is sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson, and through generous donations from people like you.